Infusion Pump Market growth is driven by a rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, and growing number of surgical procedures performed. However, factors such as product recalls, stringent regulatory requirements for new products and increasing adoption of refurbished and rental infusion pumps may restrain market growth to a certain extent during the forecast period.

Currently, Infusion Pump Market is growing at a Compound Annual Growth Rate (CAGR) of 7.0% to reach USD 20.5 billion by 2027. An infusion system consists of a pump (device) and associated disposables for delivering fluids, such as nutrients and medications, into a patient’s body in controlled amounts. These devices are efficiently used for infusion through several routes of administration, such as intravenous, epidural, arterial, subcutaneous, peritoneal, enteral, and intrathecal. They enable the delivery of solutions in a predetermined and controlled manner and are thus helpful in managing chronic diseases and associated pain.

Request for assumptions & how numbers were triangulated.
https://www.marketsandmarkets.com/requestsampleNew.asp?id=90374506

Growth Drivers
• Rising demand for ambulatory infusion pumps in home care settings
• Increasing incidence of chronic diseases along with rapid growth in geriatric population
• Growing number of surgical procedures performed
Growth Opportunities
• High growth opportunities in emerging countries
• Growing adoption of specialty infusion systems
Challenges
• Increasing incidence of medication errors and lack of wireless connectivity in most hospitals
Trends
• Smart pump-emr interoperability
• Growing focus on development of hybrid closed-loop systems/artificial pancreas device systems.
• Growing focus on specialty pumps and added advanced features.

The prominent players operating in the Infusion Pump Market are

Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), ICU Medical (US), Fresenius Kabi (Germany), and Medtronic plc (Ireland),

Download an Illustrative Overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506

North America is expected to exhibit the highest growth during the forecast period
• Increasing prevalence of chronic diseases such as obesity, heart disease, diabetes, and other chronic diseases
• Rising geriatric population,
• Increasing investment by major market players
Recent Developments
• In August 2022, Baxter International (US) has received US FDA approval for the new Novum IQ Syringe Infusion Pump (SYR) with Dose IQ Safety Software.
• In July 2022, Tandem Diabetes care (US) has acquired infusion set developer, Capillary Biomedical (US). This has expanded the product portfolio of Tandem Diabetes Care in infusion pump business segment.
• In March 2022, Fresenius Kabi (Germany) has received US FDA approval for the wireless Agilia Connect Infusion System, which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology.